Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynecol Pathol Retrieve available abstracts of 83 articles: HTML format

Single Articles

July 2025
1. ZHAO T, Hung YP, Devins KM, Young RH, et al
   The Spectrum of Vascular Lesions of the Upper Female Genital Tract: A Report of 55 Cases.
   Int J Gynecol Pathol. 2025;44:291-307.
   PubMed     Abstract available
   
   
   
2. ABBASI F, Nucci MR, Doron B, Ruskin R, et al
   Case Report: ESR1::CITED2 Fusion in a Malignant Uterine Tumor Resembling Ovarian Sex Cord Tumor.
   Int J Gynecol Pathol. 2025;44:368-373.
   PubMed     Abstract available
   
   
   
3. NISHIJIMA Y, Inoue N, Iwase A, Ikota H, et al
   Lamin A and Emerin Protein Expression Remains Consistently Low and Nuclear Size is Unchanged in Normal Endometrium, Precancerous Lesions, and Endometrioid Carcinoma.
   Int J Gynecol Pathol. 2025;44:340-348.
   PubMed     Abstract available
   
   
   
4. NEMEJCOVA K, Safanda A, Kendall Bartu M, Hajkova N, et al
   HER2 Status in Low-grade Serous Ovarian Tumors.
   Int J Gynecol Pathol. 2025;44:331-335.
   PubMed     Abstract available
   
   
   May 2025
5. JO U
   Adenomatoid Tumor Mimicking Peritoneal Carcinomatosis: A Case Report.
   Int J Gynecol Pathol. 2025;44:286-290.
   PubMed     Abstract available
   
   
   
6. CARLSON DK, Painter C, Gradecki SE, Ring KL, et al
   High-grade Endometrial Carcinomas With Solid Basaloid Morphology and Geographic Necrosis Lacking Definitive Pilomatrix-like Features: Clinicopathologic Characteristics Including Aggressive Behavior and Novel Molecular Events.
   Int J Gynecol Pathol. 2025;44:199-209.
   PubMed     Abstract available
   
   
   
7. MASAADEH AH, Dundar B, Samuelson MI, Kadera E, et al
   Bilateral Somatically Derived Germ Cell Tumors With 12p Gains Arising in High-grade Serous Carcinomas of the Ovary: A Case Report and Review of the Literature.
   Int J Gynecol Pathol. 2025;44:258-264.
   PubMed     Abstract available
   
   
   
8. YAMAGATA T, Watanabe K, Yamanoi K, Kakiuchi N, et al
   Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A Detailed Molecular Analysis.
   Int J Gynecol Pathol. 2025;44:280-285.
   PubMed     Abstract available
   
   
   
9. GULSEREN V, Sen E, Dolanbay M, Cagli F, et al
   Association of Local and Distant Organ Metastases With MELF Pattern in Endometrial Cancer.
   Int J Gynecol Pathol. 2025;44:237-241.
   PubMed     Abstract available
   
   
   
10. JAMES E, Ravikumar G, Michael Raj A J, Kulkarni K, et al
    Prognostic Significance of "High" Tumor Budding and "High" Poorly Differentiated Clusters in Endometrial Carcinomas: Independent Predictors of Lymphovascular Space Invasion and Lymph Node Metastasis.
    Int J Gynecol Pathol. 2025;44:222-229.
    PubMed     Abstract available
    
    
    
11. YOO YJ, Kim YJ, Kim YM, Kim KR, et al
    The Prognostic Value of Tumor Cell Clusters in the Fallopian Tube Lumen in Stage I Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2025;44:242-248.
    PubMed     Abstract available
    
    
    March 2025
12. TURASHVILI G, Hanley K
    Malignant Brenner Tumor of the Ovary: A Critical Reappraisal.
    Int J Gynecol Pathol. 2025;44:182-192.
    PubMed     Abstract available
    
    
    
13. MAHARJAN D, Collins K, Hou T, Umphress B, et al
    Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2025;44:193-197.
    PubMed     Abstract available
    
    
    
14. LAWSON BC, Marques-Piubelli ML, Westin SN, Malpica A, et al
    Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases.
    Int J Gynecol Pathol. 2025;44:167-173.
    PubMed     Abstract available
    
    
    
15. ZHAO X, Song Z, Liu Y, Zheng X, et al
    Synchronous Endometrial and Ovarian Endometrioid Carcinoma With MUTYH Germline Mutation: A Case Report With Genetic Analysis.
    Int J Gynecol Pathol. 2025;44:155-159.
    PubMed     Abstract available
    
    
    January 2025
16. CHRISTENSEN D, Ghafoor M, Goldberg A, De Cotiis DA, et al
    Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes.
    Int J Gynecol Pathol. 2025;44:49-55.
    PubMed     Abstract available
    
    
    
17. DEL MUNDO MM, Aguilar M, Chen H, Niu S, et al
    beta-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions.
    Int J Gynecol Pathol. 2025;44:79-87.
    PubMed     Abstract available
    
    
    
18. DE BOECK A, Nohr E, El-Hallani S, Ghatage P, et al
    POLE-mutated Endometrial "Carcinosarcoma".
    Int J Gynecol Pathol. 2025;44:72-78.
    PubMed     Abstract available
    
    
    
19. WANG L, Vasudevaraja V, Tran I, Sukhadia P, et al
    Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
    Int J Gynecol Pathol. 2025;44:88-93.
    PubMed     Abstract available
    
    
    November 2024
20. DA-ANOY A, Kang EY, Lee CH, Cheasley D, et al
    Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2024;43:617-625.
    PubMed     Abstract available
    
    
    
21. BUI CM, Azimpouran M, Balzer B, Maluf H, et al
    Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics.
    Int J Gynecol Pathol. 2024;43:586-594.
    PubMed     Abstract available
    
    
    
22. NOVIKOV FV, Anufriev AG, Efremov GD
    High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review.
    Int J Gynecol Pathol. 2024;43:626-630.
    PubMed     Abstract available
    
    
    
23. NAGY A, Niu N, Ratner E, Hui P, et al
    Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications.
    Int J Gynecol Pathol. 2024;43:631-636.
    PubMed     Abstract available
    
    
    
24. FUKUMITSU C, Sanada S, Ogasawara S, Tsuda N, et al
    CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in the Invasion of Low-grade Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2024;43:557-564.
    PubMed     Abstract available
    
    
    
25. HACHISUGA K, Kawakami M, Tomonobe H, Maenohara S, et al
    Clinical Significance of Tumor Immune Microenvironment in Endometrial Endometrioid Carcinoma, Grade 1 With DNA Mismatch Repair Protein Loss.
    Int J Gynecol Pathol. 2024;43:573-585.
    PubMed     Abstract available
    
    
    September 2024
26. VAZIRI FARD E, Imboden S, Rau T, Epstein E, et al
    p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a Prognosis Indistinguishable From Serous Carcinoma.
    Int J Gynecol Pathol. 2024;43:515-526.
    PubMed     Abstract available
    
    
    
27. MOH M, Puzyrenko A, Summey R, Rader JS, et al
    Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunoh
    Int J Gynecol Pathol. 2024;43:527-534.
    PubMed     Abstract available
    
    
    
28. HUVILA J, Jamieson A, Pors J, Hoang L, et al
    Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics.
    Int J Gynecol Pathol. 2024;43:506-514.
    PubMed     Abstract available
    
    
    
29. LIU N, Lin W, Wang Y, Yao Z, et al
    Predicting Progestin Therapy Response With PTEN, PAX2, and beta-Catenin in Patients With Endometrioid Precancer.
    Int J Gynecol Pathol. 2024;43:494-505.
    PubMed     Abstract available
    
    
    July 2024
30. MIYAMA Y, Ogasawara A, Hasegawa K, Yasuda M, et al
    Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
    Int J Gynecol Pathol. 2024;43:362-372.
    PubMed     Abstract available
    
    
    
31. GILMORE B, Logan L, McKinnon W, Everett E, et al
    Endometrial Cancer in a Family With RAD51D Gene Mutation.
    Int J Gynecol Pathol. 2024;43:349-353.
    PubMed     Abstract available
    
    
    
32. VIKI M, Morrow R
    Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in the Diagnostic Evaluation of ER Negative Ovarian Malignancy: A Case Report.
    Int J Gynecol Pathol. 2024;43:378-381.
    PubMed     Abstract available
    
    
    
33. ZHAO Z, Nadarajah R, Busmanis I
    Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case.
    Int J Gynecol Pathol. 2024;43:382-388.
    PubMed     Abstract available
    
    
    
34. GUERRIERO A, Moro M, Angerilli V, Munari G, et al
    Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
    Int J Gynecol Pathol. 2024;43:309-315.
    PubMed     Abstract available
    
    
    
35. WANG SC, Wu CH, Fu HC, Ou YC, et al
    Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Int J Gynecol Pathol. 2024;43:316-325.
    PubMed     Abstract available
    
    
    
36. AL-HUSSAINI M, McCluggage WG
    SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors.
    Int J Gynecol Pathol. 2024;43:373-377.
    PubMed     Abstract available
    
    
    June 2024
37. WALIA A, Ladwig NR, Mak JS, Rabban JT, et al
    Prevalence of Occult Ovarian Cancer and Metastatic Breast Cancer in Ovarian Ablation Specimens of Patients With Hormone Receptor-Positive Breast Cancer: Implications for Tissue Sampling Strategies, Early Ovarian Cancer Detection and Resource Utilizati
    Int J Gynecol Pathol. 2024 Jun 26. doi: 10.1097/PGP.0000000000001055.
    PubMed     Abstract available
    
    
    May 2024
38. ALROHAIBANI A, Yu Y, Gao L, McLean KM, et al
    PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian Carcinosarcomas.
    Int J Gynecol Pathol. 2024;43:284-289.
    PubMed     Abstract available
    
    
    
39. YAMAMOTO A, Nagai T, Sukeda A, Kajiwara M, et al
    Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma Component: A Case Report.
    Int J Gynecol Pathol. 2024;43:296-301.
    PubMed     Abstract available
    
    
    
40. LI Y, Chen J, Niu S
    Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Si
    Int J Gynecol Pathol. 2024;43:271-274.
    PubMed     Abstract available
    
    
    
41. XU J, Weisman PS
    Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia.
    Int J Gynecol Pathol. 2024;43:302-307.
    PubMed     Abstract available
    
    
    
42. JU B, Wu J, Sun L, Yang C, et al
    Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic Elongated and Fragmented Pattern.
    Int J Gynecol Pathol. 2024;43:233-241.
    PubMed     Abstract available
    
    
    
43. LEE Y, Choi S, Kim HS
    Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2024;43:221-232.
    PubMed     Abstract available
    
    
    March 2024
44. HAN R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al
    HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and ToGA Immunohistochemical Scoring.
    Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972.
    PubMed     Abstract available
    
    
    
45. XU J, McGregor SM, Park KJ, Weisman PS, et al
    Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like" Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1 With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible Association
    Int J Gynecol Pathol. 2024;43:145-148.
    PubMed    
    
    
    
46. BHARDWAJ S, Banet N, Gaston EC
    Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent Serous Borderline Tumor in a 16-year-old Girl.
    Int J Gynecol Pathol. 2024;43:140-144.
    PubMed     Abstract available
    
    
    
47. SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al
    HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian Mucinous Tumors.
    Int J Gynecol Pathol. 2024;43:134-139.
    PubMed     Abstract available
    
    
    
48. KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al
    Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Int J Gynecol Pathol. 2024;43:123-133.
    PubMed     Abstract available
    
    
    
49. KANG EY, Terzic T, Ghatage P, Woo L, et al
    TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Int J Gynecol Pathol. 2024;43:111-122.
    PubMed     Abstract available
    
    
    January 2024
50. FISCHER EG
    Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated Terminology of a Noteworthy Incidentaloma.
    Int J Gynecol Pathol. 2024;43:97-101.
    PubMed     Abstract available
    
    
    
51. ISE K, Tanei ZI, Oda Y, Tanikawa S, et al
    A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid Features.
    Int J Gynecol Pathol. 2024;43:41-46.
    PubMed     Abstract available
    
    
    
52. WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al
    FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Int J Gynecol Pathol. 2024;43:78-89.
    PubMed     Abstract available
    
    
    
53. KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al
    Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
    Int J Gynecol Pathol. 2024;43:25-32.
    PubMed     Abstract available
    
    
    
54. XU J, Park KJ, Weisman PS
    An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
    Int J Gynecol Pathol. 2024;43:67-69.
    PubMed    
    
    
    
55. ELMUTI L, Amundson J, Oberman E, Kamat A, et al
    Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.
    Int J Gynecol Pathol. 2024;43:90-96.
    PubMed     Abstract available
    
    
    
56. WEPY C, Nucci MR, Parra-Herran C
    Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic, Immunohistochemical, and Molecular Features.
    Int J Gynecol Pathol. 2024;43:70-77.
    PubMed     Abstract available
    
    
    November 2023
57. YOSHINO Y, Yanai S, Sawada M, Sakate S, et al
    Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With Literature Review.
    Int J Gynecol Pathol. 2023;42:544-549.
    PubMed     Abstract available
    
    
    
58. MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al
    Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:567-575.
    PubMed     Abstract available
    
    
    
59. ALNA'IRAT M, McCluggage WG, Al-Hussaini M
    Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:627-631.
    PubMed     Abstract available
    
    
    
60. STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al
    Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian Components: A Case Report With Molecular Analysis Demonstrating Multidirectional Mullerian Differentiation.
    Int J Gynecol Pathol. 2023;42:620-626.
    PubMed     Abstract available
    
    
    
61. LIN LH, Zamuco RD, Shukla PS
    Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding.
    Int J Gynecol Pathol. 2023;42:602-612.
    PubMed     Abstract available
    
    
    October 2023
62. BICER E, Bese T, Tuzun DD, Ilvan S, et al
    The Relationship Between Melatonin 1-2 Receptor Expression in Patients With Epithelial Ovarian Cancer and Survival.
    Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968.
    PubMed     Abstract available
    
    
    September 2023
63. KEANE E, Floyd R, McDonnell C, Beirne JP, et al
    Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid Adenomyoma-type Cha
    Int J Gynecol Pathol. 2023;42:466-471.
    PubMed     Abstract available
    
    
    
64. DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al
    Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2, Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
    Int J Gynecol Pathol. 2023;42:443-450.
    PubMed     Abstract available
    
    
    
65. KEYHANIAN K, Yang EJ, Howitt BE
    Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2023;42:435-442.
    PubMed     Abstract available
    
    
    
66. TALIA KL, Ratnayake G, McCluggage WG
    Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum: Report of a Case Associated With Endosalpingiosis.
    Int J Gynecol Pathol. 2023;42:496-499.
    PubMed     Abstract available
    
    
    
67. DONTHI D, Chen H, Peng Y, Niu S, et al
    Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and Omental Spread: A Case Report With Morphological, Immunohistochemical, and Molecular Analysis.
    Int J Gynecol Pathol. 2023;42:491-495.
    PubMed     Abstract available
    
    
    
68. CHIESA-VOTTERO AG
    Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
    Int J Gynecol Pathol. 2023;42:514.
    PubMed    
    
    
    
69. GUERRIERI C, Hudacko R, Anderson P
    Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Int J Gynecol Pathol. 2023;42:500-507.
    PubMed     Abstract available
    
    
    
70. CHUI MH, Murali R, Soslow RA, Matrai C, et al
    Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
    Int J Gynecol Pathol. 2023;42:472-481.
    PubMed     Abstract available
    
    
    
71. ANDRADE LALA, Alame M, Truffaux N, Croce S, et al
    Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report of a Unique Case.
    Int J Gynecol Pathol. 2023;42:508-513.
    PubMed     Abstract available
    
    
    July 2023
72. CHUI MH, Grisham RN
    Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
    Int J Gynecol Pathol. 2023;42:432-433.
    PubMed    
    
    
    
73. TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al
    Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
    Int J Gynecol Pathol. 2023;42:353-363.
    PubMed     Abstract available
    
    
    
74. BRAUN A, Reddy S, Cheng L, Gattuso P, et al
    Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
    Int J Gynecol Pathol. 2023;42:414-420.
    PubMed     Abstract available
    
    
    
75. HALL KC, Post MD, Alldredge J, Aisner DL, et al
    Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Int J Gynecol Pathol. 2023;42:403-413.
    PubMed     Abstract available
    
    
    
76. KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al
    Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary Intestinal-type Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2023;42:398-402.
    PubMed     Abstract available
    
    
    
77. LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al
    DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor: Report of a Rare Case.
    Int J Gynecol Pathol. 2023;42:421-425.
    PubMed     Abstract available
    
    
    
78. SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al
    Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies (Polyembryoma Background): A Case Report and Literature Review.
    Int J Gynecol Pathol. 2023;42:426-431.
    PubMed     Abstract available
    
    
    May 2023
79. STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al
    Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor.
    Int J Gynecol Pathol. 2023;42:241-246.
    PubMed     Abstract available
    
    
    
80. YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al
    Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A Case Report.
    Int J Gynecol Pathol. 2023;42:308-314.
    PubMed     Abstract available
    
    
    
81. OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al
    Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade Serous Carcinoma-Report of the First Case.
    Int J Gynecol Pathol. 2023;42:254-258.
    PubMed     Abstract available
    
    
    
82. MENDOZA R, Kertowidjojo E
    CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
    Int J Gynecol Pathol. 2023;42:325-326.
    PubMed    
    
    
    
83. HALLING GC, Udager AM, Skala SL
    Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
    Int J Gynecol Pathol. 2023;42:247-253.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.